In a 130-page decision handed down last month, Cote faulted Shkreli for creating two companies, Vyera and Retrophin Inc, designed to monopolize drugs so he could profit ‘on the backs’ of patients, doctors and…
kavita sangrah
In a 130-page decision handed down last month, Cote faulted Shkreli for creating two companies, Vyera and Retrophin Inc, designed to monopolize drugs so he could profit ‘on the backs’ of patients, doctors and…